"Cada pessoa é única. Assim como cada paciente, cada diagnóstico e cada tratamento. Trouxemos os princípios do tratamento individual e humanizado para Itajaí há mais de 19 anos, e dessa forma, conseguimos construir um nome sólido que tornou-se referência no atendimento diferenciado para câncer em na região. Nós acreditamos que o câncer não precisa ser o fim, mas sim, o início de uma nova fase cheia de esperança, determinação, coragem e recomeços. Como clínica, nosso compromisso é que não falte cuidado e nem falte empatia. É mostrar ao paciente que está na nossa frente, que o câncer pode ser só o início. O início de uma vida sem amarras, o início de uma vida linda, e acima de tudo, o início de uma vida feliz ao lado de quem se ama."

During the past decade, Clinica de Neoplasias Litoral conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 19 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica de Neoplasias Litoral" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Genentech, Inc." with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Merck Sharp & Dohme LLC" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica de Neoplasias Litoral" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Clinica de Neoplasias Litoral" are "Breast Cancer" (6 trials), "Prostatic Neoplasms" (3 trials), "Lupus Erythematosus, Systemic" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Clinica de Neoplasias Litoral" in a lesser frequency.

Most popular intervention types in "Clinica de Neoplasias Litoral" are "Drug" (33 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Docetaxel" (7 trials), "Paclitaxel" (7 trials), "Pembrolizumab" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de Neoplasias Litoral" are 25 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica de Neoplasias Litoral". undefined are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Clinica de Neoplasias Litoral, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de Neoplasias Litoral, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".